153 related articles for article (PubMed ID: 26969198)
1. An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II).
van Baaren GJ; Broekhuijsen K; van Pampus MG; Ganzevoort W; Sikkema JM; Woiski MD; Oudijk MA; Bloemenkamp K; Scheepers H; Bremer HA; Rijnders R; van Loon AJ; Perquin D; Sporken J; Papatsonis D; van Huizen ME; Vredevoogd CB; Brons J; Kaplan M; van Kaam AH; Groen H; Porath M; van den Berg PP; Mol B; Franssen M; Langenveld J;
BJOG; 2017 Feb; 124(3):453-461. PubMed ID: 26969198
[TBL] [Abstract][Full Text] [Related]
2. Neonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 2-year outcomes of the HYPITAT-II trial.
Zwertbroek EF; Franssen MTM; Broekhuijsen K; Langenveld J; Bremer H; Ganzevoort W; van Loon AJ; van Pampus MG; Rijnders RJP; Sikkema MJ; Scherjon SA; Woiski MD; Mol BWJ; van Baar AL; Groen H;
Am J Obstet Gynecol; 2019 Aug; 221(2):154.e1-154.e11. PubMed ID: 30940558
[TBL] [Abstract][Full Text] [Related]
3. An economic evaluation of planned immediate versus delayed birth for preterm prelabour rupture of membranes: findings from the PPROMT randomised controlled trial.
Lain SJ; Roberts CL; Bond DM; Smith J; Morris JM
BJOG; 2017 Mar; 124(4):623-630. PubMed ID: 27770483
[TBL] [Abstract][Full Text] [Related]
4. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial.
Broekhuijsen K; van Baaren GJ; van Pampus MG; Ganzevoort W; Sikkema JM; Woiski MD; Oudijk MA; Bloemenkamp KW; Scheepers HC; Bremer HA; Rijnders RJ; van Loon AJ; Perquin DA; Sporken JM; Papatsonis DN; van Huizen ME; Vredevoogd CB; Brons JT; Kaplan M; van Kaam AH; Groen H; Porath MM; van den Berg PP; Mol BW; Franssen MT; Langenveld J;
Lancet; 2015 Jun; 385(9986):2492-501. PubMed ID: 25817374
[TBL] [Abstract][Full Text] [Related]
5. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial).
Vijgen SM; van der Ham DP; Bijlenga D; van Beek JJ; Bloemenkamp KW; Kwee A; Groenewout M; Kars MM; Kuppens S; Mantel G; Molkenboer JF; Mulder AL; Nijhuis JG; Pernet PJ; Porath M; Woiski MD; Weinans MJ; van Wijngaarden WJ; Wildschut HI; Akerboom B; Sikkema JM; Willekes C; Mol BW; Opmeer BC;
Acta Obstet Gynecol Scand; 2014 Apr; 93(4):374-81. PubMed ID: 24392746
[TBL] [Abstract][Full Text] [Related]
6. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial.
Langenveld J; Broekhuijsen K; van Baaren GJ; van Pampus MG; van Kaam AH; Groen H; Porath M; Oudijk MA; Bloemenkamp KW; Groot CJ; van Beek E; van Huizen ME; Oosterbaan HP; Willekes C; Wijnen-Duvekot EJ; Franssen MT; Perquin DA; Sporken JM; Woiski MD; Bremer HA; Papatsonis DN; Brons JT; Kaplan M; Nij Bijvanck BW; Mol BW;
BMC Pregnancy Childbirth; 2011 Jul; 11():50. PubMed ID: 21736705
[TBL] [Abstract][Full Text] [Related]
7. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial.
Koopmans CM; Bijlenga D; Groen H; Vijgen SM; Aarnoudse JG; Bekedam DJ; van den Berg PP; de Boer K; Burggraaff JM; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; van Loon AJ; Lub A; Papatsonis DN; van der Post JA; Roumen FJ; Scheepers HC; Willekes C; Mol BW; van Pampus MG;
Lancet; 2009 Sep; 374(9694):979-988. PubMed ID: 19656558
[TBL] [Abstract][Full Text] [Related]
8. Neonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 5-year outcomes of the HYPITAT II trial.
Zwertbroek EF; Zwertbroek J; Broekhuijsen K; Franssen MTM; Ganzevoort W; Langenveld J; Mol BWJ; van Pampus M; Scherjon S; van Baar AL; Groen H;
Eur J Obstet Gynecol Reprod Biol; 2020 Jan; 244():172-179. PubMed ID: 31810023
[TBL] [Abstract][Full Text] [Related]
9. Economic analysis comparing induction of labour and expectant management for intrauterine growth restriction at term (DIGITAT trial).
Vijgen SM; Boers KE; Opmeer BC; Bijlenga D; Bekedam DJ; Bloemenkamp KW; de Boer K; Bremer HA; le Cessie S; Delemarre FM; Duvekot JJ; Hasaart TH; Kwee A; van Lith JM; van Meir CA; van Pampus MG; van der Post JA; Rijken M; Roumen FJ; van der Salm PC; Spaanderman ME; Willekes C; Wijnen EJ; Mol BW; Scherjon SA
Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):358-63. PubMed ID: 23910171
[TBL] [Abstract][Full Text] [Related]
10. An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre-eclampsia at term (HYPITAT trial).
Vijgen SM; Koopmans CM; Opmeer BC; Groen H; Bijlenga D; Aarnoudse JG; Bekedam DJ; van den Berg PP; de Boer K; Burggraaff JM; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; van Loon AJ; Lub A; Papatsonis DN; van der Post JA; Roumen FJ; Scheepers HC; Stigter RH; Willekes C; Mol BW; Van Pampus MG;
BJOG; 2010 Dec; 117(13):1577-85. PubMed ID: 20840526
[TBL] [Abstract][Full Text] [Related]
11. Induction of labor at 39 weeks of gestation versus expectant management for low-risk nulliparous women: a cost-effectiveness analysis.
Hersh AR; Skeith AE; Sargent JA; Caughey AB
Am J Obstet Gynecol; 2019 Jun; 220(6):590.e1-590.e10. PubMed ID: 30768934
[TBL] [Abstract][Full Text] [Related]
12. Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta-analysis.
Bernardes TP; Zwertbroek EF; Broekhuijsen K; Koopmans C; Boers K; Owens M; Thornton J; van Pampus MG; Scherjon SA; Wallace K; Langenveld J; van den Berg PP; Franssen MTM; Mol BWJ; Groen H
Ultrasound Obstet Gynecol; 2019 Apr; 53(4):443-453. PubMed ID: 30697855
[TBL] [Abstract][Full Text] [Related]
13. Immediate versus delayed induction of labour in hypertensive disorders of pregnancy: a systematic review and meta-analysis.
Li J; Shao X; Song S; Liang Q; Liu Y; Qi X
BMC Pregnancy Childbirth; 2020 Nov; 20(1):735. PubMed ID: 33243171
[TBL] [Abstract][Full Text] [Related]
14. Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial.
Koopmans CM; Bijlenga D; Aarnoudse JG; van Beek E; Bekedam DJ; van den Berg PP; Burggraaff JM; Birnie E; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; le Cessie S; van Loon AJ; Mol BW; van der Post JA; Roumen FJ; Scheepers HC; Spaanderman ME; Stigter RH; Willekes C; van Pampus MG
BMC Pregnancy Childbirth; 2007 Jul; 7():14. PubMed ID: 17662114
[TBL] [Abstract][Full Text] [Related]
15. Caesarean section rates and adverse neonatal outcomes after induction of labour versus expectant management in women with an unripe cervix: a secondary analysis of the HYPITAT and DIGITAT trials.
Bernardes TP; Broekhuijsen K; Koopmans CM; Boers KE; van Wyk L; Tajik P; van Pampus MG; Scherjon SA; Mol BW; Franssen MT; van den Berg PP; Groen H
BJOG; 2016 Aug; 123(9):1501-8. PubMed ID: 27173131
[TBL] [Abstract][Full Text] [Related]
16. An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre-eclampsia at term (HYPITAT trial).
Shennan A; Hezelgrave N
BJOG; 2010 Dec; 117(13):1575-6. PubMed ID: 21125706
[No Abstract] [Full Text] [Related]
17. Cost of Elective Labor Induction Compared With Expectant Management in Nulliparous Women.
Einerson BD; Nelson RE; Sandoval G; Esplin MS; Branch DW; Metz TD; Silver RM; Grobman WA; Reddy UM; Varner M;
Obstet Gynecol; 2020 Jul; 136(1):19-25. PubMed ID: 32541288
[TBL] [Abstract][Full Text] [Related]
18. Impact of Hypertension and Preeclampsia Intervention Trial At Near Term-I (HYPITAT-I) on obstetric management and outcome in The Netherlands.
de Sonnaville CMW; Hukkelhoven CW; Vlemmix F; Groen H; Schutte JM; Mol BW; van Pampus MG
Ultrasound Obstet Gynecol; 2020 Jan; 55(1):58-67. PubMed ID: 31486156
[TBL] [Abstract][Full Text] [Related]
19. An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre-eclampsia at term (HYPITAT trial).
Moriarty T
BJOG; 2011 May; 118(6):763; author reply 764. PubMed ID: 21481137
[No Abstract] [Full Text] [Related]
20. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL-trial).
van der Ham DP; Nijhuis JG; Mol BW; van Beek JJ; Opmeer BC; Bijlenga D; Groenewout M; Arabin B; Bloemenkamp KW; van Wijngaarden WJ; Wouters MG; Pernet PJ; Porath MM; Molkenboer JF; Derks JB; Kars MM; Scheepers HC; Weinans MJ; Woiski MD; Wildschut HI; Willekes C
BMC Pregnancy Childbirth; 2007 Jul; 7():11. PubMed ID: 17617892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
